Legal Representation
Attorney
Joshua S. Jarvis, Esq.
Application History
7 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 16, 2021 | ABN1 | O | ABANDONMENT - EXPRESS MAILED | Loading... |
| Mar 16, 2021 | MAB1 | E | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT | Loading... |
| Mar 15, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 15, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 15, 2021 | EXAR | I | TEAS EXPRESS ABANDONMENT RECEIVED | Loading... |
| Dec 3, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 19, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
House mark for pharmaceuticals for the treatment of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, neurodegenerative diseases, disorders, and conditions, metabolic diseases, disorders, and conditions, renal diseases, disorders, and conditions, ophthalmological diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Research and development of pharmaceuticals in the fields of mitochondrial diseases, disorders, and conditions, cardiovascular diseases, disorders, and conditions, musculoskeletal diseases, disorders, and conditions, neurodegenerative diseases, disorders, and conditions, oncological diseases, metabolic diseases, disorders, and conditions, renal diseases, disorders, and conditions, ophthalmological diseases, disorders, and conditions, and diseases, disorders, and conditions related to aging
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
042